Equity Compensation Plans (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Equity Compensation Plans [Line Items] | ||||
| Weighted average grant date fair value per share (in Dollars per share) | $ 800,000 | |||
| Restricted stock unit expense | $ 477 | $ 825 | $ 845 | $ 1,317 |
| Restricted Stock Units [Member] | ||||
| Equity Compensation Plans [Line Items] | ||||
| Restricted stock unit expense | $ 400 | $ 800 | $ 800 | $ 1,300 |
| 2017 Equity Incentive Plan [Member] | ||||
| Equity Compensation Plans [Line Items] | ||||
| Shares available for issuance (in Shares) | 1.8 | 1.8 | ||
| Weighted average grant date fair value per share (in Dollars per share) | $ 0.66 | |||
| 2017 Equity Incentive Plan [Member] | Restricted Stock Units [Member] | ||||
| Equity Compensation Plans [Line Items] | ||||
| Restricted stock options granted (in Shares) | 1.2 | |||
| Unrecognized stock compensation | $ 2,300 | $ 2,300 | ||
| Unrecognized stock compensation period | 1 year 7 months 6 days | |||
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|